Lv2
110 积分 2024-03-13 加入
Assessment of the impact of partial area under the curve in a bioavailability/bioequivalence study on generic prolonged-release formulations
2天前
已完结
Hyperconjugative Aromaticity-Based Circularly Polarized Luminescence Enhancement in Polyaurated Heterocycles
5天前
已完结
Macrocycle-Encircled Polynuclear Metal Clusters: Controllable Synthesis, Reactivity Studies, and Applications
5天前
已完结
Ibrutinib: first global approval
7天前
已完结
Clinical Pharmacokinetic and Pharmacodynamic Considerations in Treating Non-Hodgkin Lymphoma
8天前
已完结
Quality by design endorsed fabrication of Ibrutinib-loaded human serum albumin nanoparticles for the management of leukemia
8天前
已完结
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
12天前
已完结
Real-World Efficacy and Safety of the Combination of Rituximab, Lenalidomide, and Ibrutinib in Patients with Relapsed and/or Refractory Non-Hodgkin Lymphoma
12天前
已关闭
Phase II, Single Arm, Open Label, Single Center Study of Obinutuzumab and Ibrutinib in the Front Line Treatment of Indolent B-Cell Non-Hodgkin Lymphomas
12天前
已关闭
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma
12天前
已完结
皖公网安备34019202002308
